References and Notes
<A NAME="RD56310ST-1">1</A>
Dewick PM.
Medicinal Natural Products
2nd
ed.:
John Wiley and Sons;
Chichester:
2002.
<A NAME="RD56310ST-2">2</A>
Tietze LF.
Brasche C.
Gericke KM.
Domino Reactions in Organic Synthesis
Wiley-VCH;
Weinheim:
2006.
<A NAME="RD56310ST-3">3</A>
Serratosa F.
Xicart J.
Organic
Chemistry in Action: The Design of Organic
Synthesis
Elsevier;
New York:
1996.
<A NAME="RD56310ST-4">4</A>
Smith WA.
Bochkov AF.
Caple R.
Organic Synthesis: The Science behind the
Art
RSC;
Cambridge / U.K.:
1998.
<A NAME="RD56310ST-5">5</A>
Basile AS.
Gammal SH.
Jones EA.
Skolnick P.
J.
Neurochem.
1989,
53:
1057
<A NAME="RD56310ST-6">6</A>
Bellantuono C.
Reggi G.
Tognoni G.
Grattini S.
Drugs
1980,
19:
195
<A NAME="RD56310ST-7">7</A>
Katritzky AR.
Fan W.-Q.
Greenhill JV.
J.
Org. Chem.
1991,
56:
1299
<A NAME="RD56310ST-8">8</A>
Gupta M.
Paul S.
Gupta R.
Eur.
J. Med. Chem.
2011,
631
<A NAME="RD56310ST-9">9</A>
Deam ML.
Synthesis
1981,
322
<A NAME="RD56310ST-10">10</A>
Reddy GS.
Kumar PA.
Anand RV.
Mukkanti K.
Reddy PP.
Synlett
2009,
1463
<A NAME="RD56310ST-11">11</A>
Demydchuk BA.
Brovarets VS.
Chernega AN.
Rusanov EB.
Drach BS.
Synthesis
2006,
2323
<A NAME="RD56310ST-12">12</A>
Birkett PR.
Chapleo CB.
Mackenzie G.
Synthesis
1991,
822
<A NAME="RD56310ST-13">13</A>
Raboisson P.
Norberg B.
Casimir JR.
Bourguignon
J.-J.
Synlett
2002,
519
<A NAME="RD56310ST-14">14</A>
Zaleska B.
Trzewik B.
Grochowski J.
Serda P.
Synthesis
2003,
2559
<A NAME="RD56310ST-15">15</A>
General Procedure
for the Synthesis of Compound 4
To a suspension of 1 (1 mmol) and isocyanide 2 (1
mmol) in CH2Cl2 (4 mL) was added Et3N
(2 mmol) at r.t. After stirring for 20 h at r.t., hydrazonoyl chloride 3 (1 mmol) was added to the solution and
stirred for 10 h. Subsequently, the solvent was evaporated, and
the crude product was washed with EtOAc. The solid mixture was dissolved
in CH2Cl2 (5 mL) and washed with two 3 mL
portions of H2O, then dried (Na2SO4),
and evaporated under reduced pressure.
Selected
Spectroscopic Data for Compound 4a
Pale yellow powder,
mp 148-150 ˚C, yield 0.34 g, 90%. IR (KBr): νmax = 3419
(NH), 1658, 1548, 1442 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 1.08
(3 H, t, ³
J = 7.1
Hz, Me), 1.21 (9 H, s, CMe3), 4.14-4.15 (2 H,
m, CH2O), 6.91 (1 H, t, ³
J = 7.4 Hz,
CH), 7.25-7.30 (4 H, m, 4 CH), 7.35-7.38 (2 H, m,
2 CH), 7.60-7.62 (2 H, d, ³
J = 7.7 Hz,
2 CH), 7.79 (1 H, t, ³
J = 6.4
Hz, CH), 7.93 (1 H, t, ³
J = 6.4
Hz, CH), 8.48 (1 H, t, ³
J = 8.1
Hz, CH), 8.73 (1 H, d, ³
J = 6.4
Hz, CH), 8.85 (1 H, d, ³
J = 6.4
Hz, CH), 9.59 (1 H, br s, NH), 10.32 (1 H, br s, NH) ppm. ¹³C
NMR (125.7 MHz, CDCl3): δ = 13.9
(Me), 29.9 (CMe3), 54.7 (C), 60.3 (CH2O),
105.4 (C), 113.8 (2 CH), 121.0 (2 CH), 124.9 (C), 126.9 (CH), 127.1
(CH), 128.5 (CH), 128.7 (2 CH), 128.9 (2 CH), 130.9 (C), 135.0 (C),
143.8 (CH), 147.2 (CH), 147.5 (C), 148.3 (CH), 153.2 (C), 164.2
(C=O) ppm. MS: m/z (%) = 442
(4) [M+], 411 (75), 355 (77),
290 (28), 77 (100). Anal. Calcd (%) for C27H30N4O2 (442.24):
C, 73.28; H, 6.83; N, 12.66. Found (%): C, 72.84; H, 6.51;
N, 12.92.
<A NAME="RD56310ST-16">16</A>
Gasparrini F.
Lunnazi L.
Misiti D.
Villani C.
Acc. Chem. Res.
1995,
28:
163